Yuri Karl Peterson

Charleston, SC, United States of America

Yuri Karl Peterson

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovations of Yuri Karl Peterson

Introduction

Yuri Karl Peterson is a notable inventor based in Charleston, SC (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that promote mitochondrial biogenesis. With a total of nine patents to his name, Peterson's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents are the 5HT1F receptor agonists and mitochondrial biogenesis. These patents detail compounds that promote mitochondrial biogenesis and are useful for treating conditions such as acute kidney injury and chronic kidney disease. The compounds are described with specific formulas and include pharmaceutically acceptable salts, showcasing the innovative nature of Peterson's research.

Career Highlights

Throughout his career, Peterson has worked with esteemed organizations, including the Medical University of South Carolina Foundation for Research Development and the United States Government as represented by the Department of Veterans Affairs. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Some of his notable coworkers include Christopher C. Lindsey and Craig Cano Beeson. Their collaborative efforts have likely enhanced the scope and impact of Peterson's research.

Conclusion

Yuri Karl Peterson's contributions to the field of pharmaceutical sciences through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…